Financial Snapshot

Revenue
$405.1M
TTM
Gross Margin
66.94%
TTM
Net Earnings
-$82.78M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
173.6%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Q4 2024
Book Value
$254.6M
Q4 2024
Cash
Q4 2024
P/E
-14.77
Nov 29, 2024 EST
Free Cash Flow
-$736.0K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018
Revenue $356.3M $280.9M $213.2M $148.7M $124.8M $99.89M $79.83M
YoY Change 26.84% 31.74% 43.42% 19.15% 24.92% 25.12%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018
Revenue $356.3M $280.9M $213.2M $148.7M $124.8M $99.89M $79.83M
Cost Of Revenue $124.0M $109.3M $81.39M $52.40M $44.70M $37.00M $29.80M
Gross Profit $232.3M $171.6M $131.8M $96.30M $80.10M $62.90M $50.10M
Gross Profit Margin 65.19% 61.1% 61.83% 64.77% 64.19% 62.97% 62.76%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018
Selling, General & Admin $226.9M $231.6M $175.1M $83.43M $62.82M $46.44M $43.60M
YoY Change -2.03% 32.3% 109.87% 32.82% 35.25% 6.52%
% of Gross Profit 97.7% 134.96% 132.8% 86.64% 78.42% 73.84% 87.02%
Research & Development $112.3M $91.24M $52.27M $22.62M $18.62M $14.35M $11.38M
YoY Change 23.13% 74.58% 131.04% 21.47% 29.79% 26.12%
% of Gross Profit 48.36% 53.16% 39.64% 23.49% 23.25% 22.81% 22.71%
Depreciation & Amortization $29.49M $25.30M $21.30M $15.91M $13.92M $11.59M $9.640M
YoY Change 16.53% 18.79% 33.91% 14.25% 20.1% 20.27%
% of Gross Profit 12.69% 14.74% 16.16% 16.52% 17.38% 18.43% 19.24%
Operating Expenses $339.3M $322.9M $227.4M $106.1M $81.44M $60.79M $54.98M
YoY Change 5.08% 42.02% 114.38% 30.23% 33.96% 10.58%
Operating Profit -$136.5M -$176.6M -$116.8M -$25.67M -$15.30M -$9.494M -$14.55M
YoY Change -22.7% 51.14% 355.05% 67.81% 61.13% -34.76%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018
Interest Expense $1.854M $1.411M $1.163M $1.695M $3.043M $3.510M -$3.600M
YoY Change 31.4% 21.32% -31.39% -44.3% -13.3% -197.5%
% of Operating Profit
Other Income/Expense, Net $1.137M $889.0K -$1.162M -$1.572M -$6.775M -$5.568M -$3.639M
YoY Change 27.9% -176.51% -26.08% -76.8% 21.68% 53.01%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018
Pretax Income -$135.3M -$175.7M -$118.0M -$27.24M -$22.07M -$15.06M -$18.19M
YoY Change -22.95% 48.89% 333.06% 23.42% 46.55% -17.21%
Income Tax $1.543M $483.0K $182.0K $49.00K -$1.780M $0.00 $0.00
% Of Pretax Income
Net Earnings -$136.9M -$176.1M -$118.2M -$27.29M -$20.29M -$15.06M -$18.19M
YoY Change -22.29% 49.07% 332.95% 34.49% 34.73% -17.21%
Net Earnings / Revenue -38.42% -62.71% -55.41% -18.36% -16.26% -15.08% -22.79%
Basic Earnings Per Share -$2.51 -$3.36 -$2.37 -$0.69 -$4.50
Diluted Earnings Per Share -$2.51 -$3.36 -$2.37 -$0.69 -$4.50 -$429.0K -$517.0K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $87.52M $176.7M $313.8M $218.8M $90.30M $1.500M $10.50M
YoY Change -50.46% -43.7% 43.42% 142.3% 5920.0% -85.71%
Cash & Equivalents $87.52M $176.7M $313.8M $218.8M $90.30M $1.500M $10.50M
Short-Term Investments
Other Short-Term Assets $15.23M $11.77M $12.68M $9.000M $6.900M $5.000M $4.400M
YoY Change 29.44% -7.25% 40.94% 30.43% 38.0% 13.64%
Inventory
Prepaid Expenses
Receivables $64.86M $51.39M $40.26M $29.10M $22.00M $16.10M $12.30M
Other Receivables $28.07M $22.60M $19.59M $15.40M $12.30M $10.20M $8.700M
Total Short-Term Assets $195.7M $262.4M $386.3M $272.3M $131.5M $32.90M $36.00M
YoY Change -25.44% -32.07% 41.88% 107.07% 299.7% -8.61%
Property, Plant & Equipment $17.17M $22.24M $36.98M $29.30M $14.50M $14.20M $13.20M
YoY Change -22.8% -39.87% 26.22% 102.07% 2.11% 7.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.865M $5.090M $7.109M $3.600M $2.500M $2.700M $1.300M
YoY Change -24.07% -28.4% 97.47% 44.0% -7.41% 107.69%
Total Long-Term Assets $174.6M $107.6M $108.1M $54.40M $27.30M $26.40M $21.10M
YoY Change 62.28% -0.47% 98.76% 99.27% 3.41% 25.12%
Total Assets $370.3M $370.1M $494.5M $326.7M $158.8M $59.30M $57.10M
YoY Change
Accounts Payable $8.480M $10.84M $5.119M $4.400M $6.000M $4.200M $2.200M
YoY Change -21.74% 111.68% 16.34% -26.67% 42.86% 90.91%
Accrued Expenses $37.52M $22.74M $21.41M $19.40M $9.200M $5.100M $6.400M
YoY Change 64.98% 6.24% 10.36% 110.87% 80.39% -20.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.056M $5.172M $5.821M $4.900M $2.300M $2.000M $2.800M
YoY Change 17.09% -11.15% 18.8% 113.04% 15.0% -28.57%
Total Short-Term Liabilities $110.1M $79.04M $68.43M $55.00M $35.40M $27.90M $25.00M
YoY Change 39.32% 15.5% 24.42% 55.37% 26.88% 11.6%
Long-Term Debt $5.400M $2.725M $7.423M $6.500M $21.50M $30.30M $20.10M
YoY Change 98.17% -63.29% 14.2% -69.77% -29.04% 50.75%
Other Long-Term Liabilities $3.088M $474.0K $1.341M $1.900M $0.00 $5.500M $3.400M
YoY Change 551.48% -64.65% -29.42% -100.0% 61.76%
Total Long-Term Liabilities $8.488M $3.199M $8.764M $8.400M $21.50M $35.80M $23.50M
YoY Change 165.33% -63.5% 4.33% -60.93% -39.94% 52.34%
Total Liabilities $118.9M $82.24M $77.20M $63.40M $56.90M $63.70M $48.50M
YoY Change 44.55% 6.53% 21.76% 11.42% -10.68% 31.34%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding 54.56M shares 52.44M shares 49.89M shares 39.52M shares 20.30M shares
Diluted Shares Outstanding 54.56M shares 52.44M shares 49.89M shares 39.52M shares 20.30M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.2225 Billion

About Phreesia, Inc.

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The company is headquartered in Wilmington, Delaware and currently employs 1,438 full-time employees. The company went IPO on 2019-07-18. The firm's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The firm also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The firm's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.

Industry: Services-Business Services, NEC Peers: Veradigm Inc. American Well Corp MultiPlan Corp Certara, Inc. Nutex Health, Inc. GoodRx Holdings, Inc. NEXTGEN HEALTHCARE, INC. Simulations Plus, Inc. Schrodinger, Inc.